Citadel Advisors’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $656K | Buy |
287,500
+255,600
| +801% | +$589K | ﹤0.01% | 8644 |
|
|
2025
Q4 | $89.3K | Hold |
31,900
| – | – | ﹤0.01% | 11725 |
|
|
2025
Q3 | $153K | Sell |
31,900
-3,000
| -9% | -$19.1K | ﹤0.01% | 11516 |
|
|
2025
Q2 | $318K | Sell |
34,900
-12,700
| -27% | -$93.6K | ﹤0.01% | 9683 |
|
|
2025
Q1 | $430K | Sell |
47,600
-41,000
| -46% | -$433K | ﹤0.01% | 8811 |
|
|
2024
Q4 | $1.16M | Buy |
88,600
+42,500
| +92% | +$567K | ﹤0.01% | 6720 |
|
|
2024
Q3 | $723K | Buy |
46,100
+17,900
| +63% | +$271K | ﹤0.01% | 7478 |
|
|
2024
Q2 | $381K | Sell |
28,200
-99,600
| -78% | -$2.04M | ﹤0.01% | 8621 |
|
|
2024
Q1 | $3.54M | Buy |
127,800
+90,500
| +243% | +$2.01M | ﹤0.01% | 4521 |
|
|
2023
Q4 | $719K | Buy |
37,300
+16,300
| +78% | +$295K | ﹤0.01% | 7337 |
|
|
2023
Q3 | $339K | Sell |
21,000
-12,200
| -37% | -$217K | ﹤0.01% | 8913 |
|
|
2023
Q2 | $632K | Buy |
33,200
+7,400
| +29% | +$132K | ﹤0.01% | 7427 |
|
|
2023
Q1 | $375K | Sell |
25,800
-42,100
| -62% | -$754K | ﹤0.01% | 8906 |
|
|
2022
Q4 | $1.33M | Sell |
67,900
-18,200
| -21% | -$355K | ﹤0.01% | 6273 |
|
|
2022
Q3 | $2.08M | Buy |
86,100
+13,800
| +19% | +$425K | ﹤0.01% | 5527 |
|
|
2022
Q2 | $2.27M | Buy |
72,300
+1,400
| +2% | +$50.7K | ﹤0.01% | 5292 |
|
|
2022
Q1 | $3.12M | Sell |
70,900
-17,400
| -20% | -$747K | ﹤0.01% | 5082 |
|
|
2021
Q4 | $3.84M | Buy |
88,300
+6,900
| +8% | +$271K | ﹤0.01% | 4840 |
|
|
2021
Q3 | $2.55M | Sell |
81,400
-26,700
| -25% | -$1.05M | ﹤0.01% | 5762 |
|
|
2021
Q2 | $4.58M | Buy |
108,100
+36,200
| +50% | +$1.41M | ﹤0.01% | 4631 |
|
|
2021
Q1 | $2.7M | Sell |
71,900
-30,500
| -30% | -$954K | ﹤0.01% | 5693 |
|
|
2020
Q4 | $2.77M | Sell |
102,400
-8,500
| -8% | -$219K | ﹤0.01% | 4709 |
|
|
2020
Q3 | $2.79M | Buy |
110,900
+55,500
| +100% | +$809K | ﹤0.01% | 4104 |
|
|
2020
Q2 | $422K | Buy |
55,400
+6,600
| +14% | +$48.3K | ﹤0.01% | 7356 |
|
|
2020
Q1 | $447K | Buy |
48,800
+20,500
| +72% | +$124K | ﹤0.01% | 6644 |
|
|
2019
Q4 | $146K | Buy |
28,300
+1,500
| +6% | +$9.63K | ﹤0.01% | 8378 |
|
|
2019
Q3 | $156K | Buy |
+26,800
| New | +$120K | ﹤0.01% | 8282 |
|
|
2019
Q2 | – | Sell |
-16,900
| Closed | -$69K | – | 9660 |
|
|
2019
Q1 | $69K | Buy |
+16,900
| New | +$107K | ﹤0.01% | 8696 |
|
|
2018
Q4 | – | Sell |
-21,400
| Closed | -$354K | – | 9585 |
|
|
2018
Q3 | $354K | Buy |
+21,400
| New | +$364K | ﹤0.01% | 7301 |
|
|
2017
Q1 | – | Sell |
-6,900
| Closed | -$244K | – | 7865 |
|
|
2016
Q4 | $244K | Buy |
+6,900
| New | +$233K | ﹤0.01% | 5987 |
|
|
2016
Q1 | – | Sell |
-1,300
| Closed | -$47K | – | 7622 |
|
|
2015
Q4 | $47K | Sell |
1,300
-1,500
| -54% | -$54.3K | ﹤0.01% | 7371 |
|
|
2015
Q3 | $89K | Buy |
+2,800
| New | +$95.3K | ﹤0.01% | 7065 |
|
Other funds holding ACH
CCM
ICM
VCM
VPM
Citadel Advisors's ACH Position: Q1 2026 in Review
Citadel Advisors reduced its Accendra Health (ACH) stake by 86% in Q1 2026, selling an estimated $3.19M and leaving 235,139 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #9131.
Citadel Advisors first reported a position in ACH in Q2 2013 and has held it in 47 quarters since. The position peaked at $57.6M in Q4 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.
- Citadel Advisors held 235,139 shares of Accendra Health worth $536K as of Q1 2026.
- Citadel Advisors sold 1,386,872 Accendra Health shares in Q1 2026, an estimated $3.19M.
- Accendra Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9131 holding.
- Citadel Advisors first reported a position in Accendra Health in Q2 2013 and has held it in 47 quarters since.
- Citadel Advisors's Accendra Health position peaked at $57.6M in Q4 2021.
- 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.